US Patent No: 6,267,985

Number of patents in Portfolio can not be more than 2000

Clear oil-containing pharmaceutical compositions

Stats

ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

The present invention relates to pharmaceutical compositions and methods for improved solubilization of triglycerides and improved delivery of therapeutic agents. Compositions of the present invention include a triglyceride and a carrier, where the carrier is formed from a combination of at least two surfactants, at least one of which is hydrophilic. Upon dilution with an aqueous solvent, the composition forms a clear, aqueous dispersion of the triglyceride and surfactants. An optional therapeutic agent can be incorporated into the composition, or can be co-administered with the composition. The invention also provides methods of enhancing triglyceride solubility and methods of treatment with therapeutic agents using these compositions.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
LIPOCINE INC.SALT LAKE CITY, UT14

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Feng-Jing Salt Lake City, UT 28 1155
Patel, Mahesh V Salt Lake City, UT 49 1239

Cited Art

Patent Info (Count) # Cites Year
 
ATHENA NEUROSCIENCES, INC. (4)
5,444,041 Convertible microemulsion formulations 85 1992
5,633,226 Convertible microemulsion formulations 25 1995
5,646,109 Convertible microemulsion formulations 22 1995
5,707,648 Transparent liquid for encapsulated drug delivery 73 1995
 
R.P. SCHERER CORPORATION (4)
4,727,109 Pharmaceutical preparation with an active substance of low solubility in water and gastric juices 20 1985
5,071,643 Solvent system enhancing the solubility of pharmaceuticals for encapsulation 44 1987
5,376,688 Enhanced solubility pharmaceutical solutions 26 1992
5,645,856 Delivery systems for hydrophobic drugs 77 1995
 
NOVARTIS AG (3)
4,388,307 Galenical compositions 121 1982
5,342,625 Pharmaceutical compositions comprising cyclosporins 175 1992
5,589,455 Cyclosporin-containing soft capsule compositions 51 1995
 
PHARMACIA & UPJOHN (2)
5,665,379 Lipid particle forming matrix, preparation and use thereof 22 1994
5,626,869 Pharmaceutical composition containing a defined lipid system 25 1995
 
AAIPHARMA SERVICES CORP. (1)
5,206,219 Oral compositions of proteinaceous medicaments 127 1991
 
AMERICAN PHARMED LABS, INC. (1)
5,120,710 Oral lipid medicinal composition 21 1990
 
BIOGLAN LABORATORIES LIMITED (1)
4,572,915 Clear micellized solutions of fat soluble essential nutrients 37 1984
 
BIOMOLECULAR PRODUCTS, INC. (1)
5,741,822 Mixed lipid-bicarbonate colloidal particles for delivering drugs 12 1994
 
BIONUMERIK PHARMACEUTICALS, INC. (1)
5,726,181 Formulations and compositions of poorly water soluble camptothecin derivatives 39 1995
 
BRISTOL-MYERS COMPANY (1)
4,713,246 Etoposide oral dosage form 21 1986
 
CALIFORNIA BIOTECHNOLOGY INC. (1)
4,994,439 Transmembrane formulations for drug administration 104 1989
 
HANMI PHARM. CO., LTD. (1)
5,639,474 Cyclosporin soft capsule composition 35 1995
 
HEMAGEN/PFC (1)
5,616,330 Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same 30 1994
 
HOFFMANN-LA ROCHE INC. (1)
5,747,066 Mixed micelles 13 1996
 
INSTITUTE FOR ADVANCED SKIN RESEARCH, INC. (1)
5,948,825 Microemulsion preparation containing a slightly absorbable substance 5 1995
 
ISP CAPITAL, INC. (1)
5,300,529 Stable, clear, efficacious aqueous microemulsion compositions containing a high loading of a water-insoluble, agriculturally active chemical 13 1993
 
KABI PHARMACIA AB (1)
5,244,925 Emulsion for parenteral administration 16 1991
 
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (1)
5,686,105 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery 26 1995
 
MONTERESEARCH S.R.L. (1)
5,656,277 Nor- and homo- bile acids derivatives as absorption enhancers for medicaments 11 1994
 
MULLER, BERND W. (1)
4,719,239 Pharmaceutical multicomponent systems and method of preparing same 99 1985
 
PATRALAN LIMITED (1)
5,656,289 Pharmaceutical formulations that have a biologically active hydrophilic phase and a chylomicra-containing hydrophobic phase 37 1994
 
PII DRUG DELIVERY, LLC (1)
5,532,002 Gelatin pharmaceutical formulations 33 1994
 
RENTSCHLER ARZNEIMITTEL GMBH & CO. (1)
5,614,491 Liquid preparations containing cyclosporin and process for preparing same 34 1994
 
SANDOZ LTD. (1)
5,639,724 Cyclosporin galenic forms 67 1993
 
STERLING DRUG INC. (1)
5,145,684 Surface modified drug nanoparticles 448 1991
 
T.I.L. MEDICAL LTD. (1)
4,944,949 Pharmaceutical delivery systems 61 1987
 
THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (1)
5,817,320 In ovo immunization of avian embryos with oil-emulsion vaccines 13 1996
 
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (1)
5,766,629 Oral cyclosporin formulations 32 1996
 
TROPONWERKE GMBH & CO. KG, A CORP. OF GERMANY (1)
4,731,384 Etofenamate formulation 16 1986
 
WATSON LABORATORIES, INC. (1)
5,858,401 Pharmaceutical composition for cyclosporines 42 1997
 
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (1)
5,364,632 Medicinal emulsions 99 1993
 
ZENECA LIMITED (1)
5,731,355 Pharmaceutical compositions of propofol and edetate 39 1997
 
OTHER [CHECK PATENT PROFILE FOR ASSIGNMENT INFORMATION] (2)
5,350,741 Enteric formulations of physiologically active peptides and proteins 61 1992
5,653,987 Liquid formulations for proteinic pharmaceuticals 65 1995

Patent Citation Ranking

Forward Cites

Patent Info (Count) # Cites Year
 
ALLERGAN, INC. (9)
6,635,654 Ophthalmic compositions containing loratadine 0 2003
7,297,679 Cyclosporin compositions 2 2005
7,276,476 Cyclosporin compositions 2 2005
7,202,209 Cyclosporin compositions 4 2005
7,501,393 Pharmaceutical compositions comprising cyclosporins 3 2005
7,288,520 Cyclosporin compositions 9 2005
8,288,348 Cyclosporin compositions 0 2006
7,745,400 Prevention and treatment of ocular side effects with a cyclosporin 1 2006
8,211,855 Cyclosporin compositions 1 2007
 
AFFINIUM PHARMACEUTICALS, INC. (8)
7,790,709 Heterocyclic compounds, methods of making them and their use in therapy 1 2003
7,879,872 Compositions comprising multiple bioactive agents, and methods of using the same 1 2005
7,741,339 Fab I inhibitors 2 2007
8,318,720 Acrylamide derivatives as Fab I inhibitors 0 2007
8,263,613 Salts, prodrugs and polymorphs of fab I inhibitors 0 2008
7,790,716 Fab I inhibitors 2 2009
8,153,652 Fab I inhibitors 0 2010
8,173,646 FAB I inhibitors 0 2010
 
ANTARES PHARMA, IPL, AG (8)
7,425,340 Permeation enhancing compositions for anticholinergic agents 0 2005
7,335,379 Transdermal pharmaceutical formulation for minimizing skin residues 6 2006
8,067,399 Method and apparatus for transdermal or transmucosal application of testosterone 0 2006
7,387,788 Pharmaceutical compositions of nicotine and methods of use thereof 5 2006
7,404,965 Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels 2 2006
7,470,433 Formulations for transdermal or transmucosal application 1 2007
8,268,346 Methods of treating hot flashes with formulations for transdermal or transmucosal application 0 2007
8,338,400 Methods and apparatus for transdermal or transmucosal application of testosterone 0 2011
 
CELLRESIN TECHNOLOGIES, LLC (8)
7,166,671 Grafted cyclodextrin 12 2003
7,385,004 Enhanced lubrication in polyolefin closure with polyolefin grafted cyclodextrin 7 2004
8,148,466 Amphoteric grafted barrier materials 0 2005
7,795,333 Grafted cyclodextrin 1 2006
7,365,123 Grafted cyclodextrin 7 2006
7,605,199 Grafted cyclodextrin 1 2006
8,334,343 Grafted cyclodextrin 0 2007
8,129,450 Articles having a polymer grafted cyclodextrin 2 2007
 
SOFT GEL TECHNOLOGIES, INC. (4)
8,124,072 Solubilized CoQ-10 0 2003
8,105,583 Solubilized CoQ-10 0 2004
8,147,826 Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene 0 2005
8,343,541 Ubiquinol and alpha lipoic acid compositions 0 2008
 
CEPHALON, INC. (3)
7,297,346 Pharmaceutical formulations of modafinil 1 2002
7,229,644 Pharmaceutical formulations of modafinil 2 2002
8,268,892 Pharmaceutical formulations of modafinil 0 2008
 
GALDERMA S.A. (3)
7,915,243 Topical skin care composition 1 2004
7,939,516 Topical skin care composition 0 2007
8,247,395 Topical skin care composition 0 2011
 
WATSON LABORATORIES, INC. (3)
7,988,995 Pharmaceutical compositions for lipophilic drugs 0 2002
8,119,157 Pharmaceutical compositions for lipophilic drugs 0 2006
7,799,340 Pharmaceutical compositions for lipophilic drugs 0 2007
 
ARENA PHARMACEUTICALS, INC. (2)
8,362,248 Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto 0 2006
8,410,119 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto 0 2009
 
DEXCEL LTD. (2)
7,026,290 Dispersible concentrate for the delivery of cyclosprin 3 1999
7,732,404 Pro-nanodispersion for the delivery of cyclosporin 0 2006
 
GALEPHAR PHARMACEUTICAL RESEARCH, INC. (2)
7,435,427 Pharmaceutical semi-solid composition of isotretinoin 0 2001
8,367,102 Pharmaceutical semi-solid composition of isotretinoin 0 2007
 
LIPOCINE INC. (2)
6,720,001 Emulsion compositions for polyfunctional active ingredients 49 1999
6,761,903 Clear oil-containing pharmaceutical compositions containing a therapeutic agent 15 2001
 
NAIDU LP (2)
7,956,031 Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy 3 2006
8,021,659 Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof 1 2006
 
NICOX S.A. (2)
7,736,666 Self emulsifying drug delivery system 0 2001
7,815,933 Self emulsifying drug delivery system 0 2002
 
OTSUKA PHARMACEUTICAL CO., LTD. (2)
7,825,130 PTEN inhibitor or Maxi-K channels opener 0 2004
8,329,731 PTEN inhibitor or Maxi-K channels opener 0 2009
 
PAUL ROYALTY FUND, L.P. (2)
7,097,849 Injectable aqueous dispersions of propofol 0 1999
7,041,705 Injectable aqueous dispersions of propofol 3 2001
 
PBM PHARMACEUTICALS, INC. (2)
8,075,910 Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions 0 2005
8,173,160 Compositions comprising edible oils and vitamins and/or minerals and methods for making the compositions 0 2005
 
RTP PHARMA INC. (2)
6,979,456 Anticancer compositions 12 1999
6,726,919 Injectable dispersion of propofol 14 2001
 
SANTEN PHARMACEUTICAL CO., LTD. (2)
8,222,271 Formulations and methods for vascular permeability-related diseases or conditions 0 2007
8,367,097 Liquid formulations for treatment of diseases or conditions 0 2010
 
SUPERNUS PHARMACEUTICALS, INC (2)
7,011,846 Oral capsule formulation with increased physical stability 0 2002
7,022,337 Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect 6 2003
 
VIRUN, INC. (2)
8,282,977 Compositions containing non-polar compounds 1 2009
8,337,931 Compositions containing non-polar compounds 0 2009
 
ABBVIE INC. (1)
8,362,013 Salt of ABT-263 and solid-state forms thereof 0 2010
 
B. BRAUN MEDICAL, INC. (1)
7,323,206 Reagents and methods for all-in-one total parenteral nutrition for neonates and infants 2 2004
 
BEIERSDORF AG (1)
7,052,716 Cosmetic and dermatological preparations comprising an effective content of bile acids, their salts and/or their derivatives 0 1999
 
BEND RESEARCH, INC. (1)
8,309,129 Nanoparticles comprising a drug, ethylcellulose, and a bile salt 0 2008
 
BORKAN, LIONEL (1)
8,287,904 Stable soft capsule dosage form for acetylsalicylic acid 0 2010
 
CARGILL, INCORPORATED (1)
6,623,780 Aqueous dispersible sterol product 13 2002
 
CLARUS THERAPEUTICS, INC. (1)
8,241,664 Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same 0 2006
 
CYDEX, INC. (1)
6,869,939 Formulations containing amiodarone and sulfoalkyl ether cyclodextrin 0 2002
 
EGALET LTD. (1)
8,298,581 Matrix compositions for controlled delivery of drug substances 0 2004
 
GENERAL TOPICS S.R.L. (1)
7,169,811 Composition based on ethyl ester of linoleic acid and triethyl ester of citric acid for topical use in the treatment of seborrhea and acne 0 2002
 
GILEAD PHARMASSET LLC (1)
8,173,621 Nucleoside cyclicphosphates 0 2009
 
HILL DERMACEUTICALS (1)
7,544,674 Topical skin care composition 1 2002
 
HILL DERMACEUTICALS, INC. (1)
7,169,401 Topical skin care composition containing refined peanut oil 0 2004
 
HOVID BERHAD (1)
6,596,306 Drug delivery system:formulation for fat-soluble drugs 1 2000
 
ISIS PHARMACEUTICALS, INC. (1)
8,039,444 Antisense permeation enhancers 0 2006
 
LODERS CROKLAAN USA LLC (1)
7,582,317 Food supplements comprising, as a health component, sargahydroquinoic acid or derivative thereof 0 2002
 
LUPIN ATLANTIS HOLDINGS, S.A. (1)
8,026,281 Treating metabolic syndrome with fenofibrate 0 2005
 
LYFJATHROUN HF. (1)
6,855,332 Absorption promoting agent 1 2002
 
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT (1)
7,169,819 Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same 3 2001
 
NITTO DENKO CORPORATION (1)
8,003,621 Drug carriers 1 2008
 
NOSTRUM PHARMACEUTICALS, INC. (1)
7,897,179 Pharmaceutical composition containing water soluble drug 0 2004
 
PLIVA, INC. (1)
7,452,552 Pharmaceutical compositions for lipophilic drugs 0 2007
 
PROMETIC BIOSCIENCES INC. (1)
7,745,488 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors 0 2002
 
RPG LIFE SCIENCES LIMITED (1)
7,056,530 Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities 0 2000
 
SAMSUNG ELECTRO-MECHANICS CO., LTD. (1)
7,414,441 Output buffer circuit 1 2006
 
SANOFI (1)
6,528,539 Stable formulation containing fumagillin 1 2001
 
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (1)
6,869,603 Lipoprotein lipase and lipoprotein lipase activators in the treatment of inflammatory conditions 0 2002
 
TRANSFORM PHARMACEUTICALS, INC. (1)
6,919,370 Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof 7 2001
 
UNIVERSITY OF PITTSBURGH (1)
6,559,139 Combination chemotherapy 5 2000
 
ZOETIS W LLC (1)
7,687,471 Benzimidazole non-aqueous compositions 0 2006
 
OTHER [CHECK PATENT PROFILE FOR ASSIGNMENT INFORMATION] (3)
7,338,971 Treatment of inflammatory, cancer, and thrombosis disorders 0 2001
7,374,772 Topical antifungal treatment 0 2002
8,148,416 Treatment of inflammatory, cancer, and thrombosis disorders 0 2008

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 31, 2013
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00